$PFE News A tale of two drug companies 4:13 p.m. Dec. 5,

New Post Public Reply Private Reply Replies (0) Message Board

Dec 6, 2013 at 12:29 PM

$PFE News

A tale of two drug companies 4:13 p.m. Dec. 5, 2013 - Mark Hulbert
3 low-risk stocks for market skeptics 6:15 a.m. Dec. 5, 2013 - Jeff Reeves
DuPont, Pfizer are top decliners in Dow index 4:01 p.m. Dec. 3, 2013 - Polya Lesova
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Where's the market oopmh? Cisco and a turnaround on Exxon Mobil 8:45 a.m. Nov. 13, 2013 - blogs.marketwatch.com
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan

Pfizer Adopts PhRMA’s Transparency Prescription 3:47 p.m. Dec. 5, 2013 - Wall St. Cheat Sheet
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy 12:43 p.m. Dec. 5, 2013 - Seeking Alpha
Pfizer to broaden access to clinical trial data 12:40 p.m. Dec. 5, 2013 - Seeking Alpha
Breast Cancer Drug Data Boosts Puma Biotechnology 10:15 a.m. Dec. 5, 2013 - Investors Business Daily
Goldman Sachs Removes Pfizer And Adds AbbVie To Its Conviction Buy List: Should You? 7:50 a.m. Dec. 5, 2013 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Stocks vs. Bonds 8:24 p.m. Dec. 4, 2013 - TheStreet.com
Companies Say Goodbye to the 'Burbs 8:21 p.m. Dec. 4, 2013 - WSJ.com
Pfizer: Transformation Pace And Oncology Success Determine Potential Returns 4:40 p.m. Dec. 4, 2013 - Seeking Alpha
Pfizer cuts 150 jobs in Ireland 3:16 p.m. Dec. 4, 2013 - Seeking Alpha
Pfizer Expands Clinical Trial Data Access Policy, Launches Data Access Portal 11:10 a.m. Dec. 4, 2013 - benzinga.com
Meet the Preliminary 2014 Dogs of the Dow: Dividends Galore 11:09 a.m. Dec. 4, 2013 - 247WallSt.com
Medicines Co. Acquires Rempex Pharma; Street Applauds 10:21 a.m. Dec. 4, 2013 - Investors Business Daily
Stock Market News for December 4, 2013 - Market News 10:06 a.m. Dec. 4, 2013 - Zacks.com
Best Biotech CEO of 2013: Your Vote Counts 8:07 a.m. Dec. 4, 2013 - TheStreet.com
Pfizer Inc (PFE): Today's Featured Drugs Laggard 5:03 p.m. Dec. 3, 2013 - TheStreet.com
Dow Today: Pfizer (PFE) Lower 1:30 p.m. Dec. 3, 2013 - TheStreet.com
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst 10:01 a.m. Dec. 3, 2013 - Seeking Alpha
Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More 8:29 a.m. Dec. 3, 2013 - 247WallSt.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com

Pfizer Expands Clinical Trial Data Access Policy And Launches Data Access Portal 12:09 p.m. Dec. 4, 2013 - BusinessWire
Bullish Stocks Commentary: Pfizer Inc, Zynga Inc, OCZ Technology Group, EnteroMedics Inc 9:01 a.m. Dec. 4, 2013 - ACCESSWIRE
Traders Buzz: Pfizer Inc, Chesapeake Energy Corporation, Alcatel Lucent SA, Advanced Micro Devices 10:02 a.m. Dec. 3, 2013 - ACCESSWIRE
Pfizer Acquires Polocard, Poland's Leading Over-The-Counter Heart Attack Prevention Brand 8:30 a.m. Dec. 2, 2013 - BusinessWire
New Products, Positive Clinical Trial Results, FDA Submissions and Stock Price Updates - Research Report on Pfizer, Cubist, Zoetis, Edwards Lifesciences, and C.R. Bard 8:00 a.m. Nov. 28, 2013 - PR Newswire
FDA Approvals, New Appointments, and Official Statements - Research Report on Pfizer, Aetna, Lilly, GSK, and Sanofi 8:00 a.m. Nov. 27, 2013 - PR Newswire
Just in Time for Peak Travel Season, Introducing New Robitussin(R) DM Max Liquid-Filled Capsules 9:00 a.m. Nov. 25, 2013 - BusinessWire
Upcoming Conference Schedules, Orphan Drug Designations and Stock Price Updates - Research Report on Pfizer, ICU Medical, CONMED, Gentium, and Repros Therapeutics 8:00 a.m. Nov. 25, 2013 - PR Newswire
Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV 9:00 a.m. Nov. 22, 2013 - PR Newswire
Pfizer's XALKORI(R) Granted Regular FDA Approval 11:00 a.m. Nov. 21, 2013 - BusinessWire
Pfizer and GSK to Initiate Study of Novel Combination Therapy in Patients with Melanoma 8:00 a.m. Nov. 21, 2013 - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Nov. 21, 2013 - PR Newswire
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer 7:00 a.m. Nov. 21, 2013 - GlobeNewswire
Notes Redemption, Upcoming Presentations, and Manufacturing Investments - Research Report on Pfizer, Baxter, Lilly, UnitedHealth Group, and Align Technology 8:00 a.m. Nov. 19, 2013 - PR Newswire
Pfizer Announces FDA Approval of Supplemental Application to Expand XELJANZ(R) (tofacitinib citrate) Labeling to Include Additional Patient-Reported Outcomes Data for Adults with Moderately to Severely Active Rheumatoid Arthritis 4:47 p.m. Nov. 18, 2013 - BusinessWire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014 8:30 a.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Athersys Recognized Among Fastest Growing Companies in North America on Deloitte's 2013 Technology Fast 500(TM) 2:00 p.m. Nov. 13, 2013 - GlobeNewswire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Busch Gardens' Holiday Extravaganza Lights Up 2026

A Dazzling Holiday Transformation Awaits Forget the mundane holiday light displays. Busch Gardens is cranking it up a notch with their annual Christmas Town spectacle, kicking off on November 13. With two parks—Tampa Bay and Williamsburg—each delivering a unique experience, prepare for an immersive dive into holiday cheer that's packed with glitz, entertainment, and,...

Banco Santander's Troubles: Legal Heat on SAN

Brazilian Turbulence Shakes Banco Santander Imagine getting hit twice in a single week, once by a surprise election result and again by numbers that don't add up. That's the gut-wrenching scenario Banco Santander's (NYSE: SAN) investors are facing. After Brazil's unexpected election outcome, investor jitters translated into a 3.7% drop on October 26, 2026. Not two days...

Pelvic Health Initiative Aids Women in Need

Stepping Up For Better Health You don't see this kind of news getting plastered across the financial pages much—the human side of health. EliHealth Initiative's making strides in a realm many don’t even want to openly discuss: bladder leaks in women. Sounds unglamorous, maybe, but for millions, it's a daily ordeal. Slapping on pads and plotting bathroom routes? That's...

Summit Hotel Welcomes New CFO, Promotes Veteran COO

Summit Hotel Properties Shakes Up Leadership Ah, the hotel industry. Sometimes as glitz and glam as Beverly Hills, sometimes as harried as a concierge juggling suitcases. Now, Summit Hotel Properties is playing its hand, reshuffling the deck with some keen leadership moves. Swapping out the four of spades for some aces, if you ask me. On November 1st, they’re bringing...

Sage Longboat Key Condos Battle Florida's Marine Climate

Building Resilience on Florida's Shores If you've ever had your eyes on some beachfront real estate down in Florida, you'd know it's not all sandy beaches and sunsets. It's a constant battle against the elements, my friends. The Sage Longboat Key condominiums in Sarasota have taken this challenge head-on with some serious innovation. The Condominium Dream Sitting pretty...

JOIA Rose Hall Revives Jamaican Luxury Experience

A New Chapter for Jamaican Luxury If there's one thing that gets the blood pumping, it's a massive overhaul of a decades-old resort, especially one sitting pretty on Montego Bay's golden shores. December 1, 2026, marks the return of JOIA Rose Hall to the hospitality scene—shiny, revamped, and all about delivering an oasis fueled by authentic Jamaican culture. Forget...

Tata's $450M Bet on India's AI Infrastructure

The Big Bet on AI Infrastructure Here comes Tata Communications, tossing nearly USD 450 million into the pot, betting on a vision that could change India's digital backbone. This isn't just some drop in the bucket; they're talking about laying down 10,000 kilometers of fiber for India's AI super highway. It's a gutsy move, and frankly, it's about time someone shook things...

Cerebras Faces Durability Allegations: Investor Alert

Cracks in Cerebras' Processor Promises? When you dance with high-stakes tech stocks, sometimes you end up stepping on a few toes. This seems to ring true as Cerebras Systems (CBRS) dances its way into hot water. Allegations from Culper Research suggest their fancy AI processors, which are supposed to be the poster children of reliability, might bow out early. Digging...

Max Stock Gears Up for Q3 Earnings Report Nov. 17

Max Stock's Q3 Earnings Anticipation Ah, it’s that time again—when we wait with bated breath for another round of quarterly earnings. Max Stock Ltd. (TASE: MAXO) is prepping to spill the beans on their third quarter 2026 performance, with a conference call scheduled for November 17. Big day? You bet. Who's Leading the Call? The brains behind the operation, CFO Paz Oz...

Keith Strachan Elevates The Master Group's Strategy

Strachan Steps Up as Chief Commercial Officer Keith Strachan is stepping into the role of Chief Commercial Officer at The Master Group—big news up in St-Bruno-de-Montarville. Now, those not neck-deep in HVAC-R might shrug this one off, but for those eyeing the industry, this is where the cards start to shuffle in North America. Master’s shift isn't just paper-pushing;...